Lung Cancer Immunotherapies Show Promise, But New Directions Needed
Results from two cancer vaccine studies suggest that lung cancer patients may benefit from immunotherapy, David Carbone (Vanderbilt-Ingram Cancer Center) concluded at the American Society of Clinical Oncology's annual meeting June 4 in Atlanta
You may also be interested in...
Antigenics is seeing salvation for its Oncophage cancer vaccine based on signs of a clinically significant improvement in a subgroup of patients with a better prognosis in its Phase III renal cell carcinoma trial
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials